The major histocompatibility complex (MHC) is located in chromosome 6p21 and contains crucial regulators of immune response, including human leucocyte antigen (HLA) genes, alongside other genes with nonimmunological roles. More recently, a repertoire of noncoding RNA genes, including expressed pseudogenes, has also been identified.
The MHC is the most gene-dense region of the human genome (Table 1) , containing a diversity of genes involved in major physiologic phenomena (Horton et al., 2004; Shiina, Hosomichi, Inoko, & Kulski, 2009; Vandiedonck & Knight, 2009; Xie et al., 2003) . The region is clearly enriched for genes encoding molecules participating in immune and inflammatory pathways (Horton et al., 2004 (Horton et al., , 2008 Shiina et al., 2009; Traherne, 2008; Trowsdale & Knight, 2013) (Table 2) , and about 60% of the gene content is involved in nonimmunological roles (Shiina et al., 2009; Vandiedonck & Knight, 2009 ). Of the total 677 genes, there are still 60 without sufficient characterization (open reading frames or uncharacterized loci). The extended MHC (xMHC) contains 1.5% of the genes in OMIM and 6.4% of genomewide significant single nucleotide polymorphism (SNP) associations in the NHGRI/EBI GWAS catalog (Ripke et al., 2013) . Before the GWAS era, the list of traits and diseases that show MHC associations in mammals was already very long and included a variety of conditions from reproductive issues (Kostyu, 1994; Lerner & Finch, 1991) , to cancer (Chaudhuri et al., 2000; de Jong et al., 2003; DeWolf, Lange, Einarson, & Yunis, 1979; Diepstra et al., 2005 ; M. T. Dorak et al., 1999; Klitz, Aldrich, Fildes, Horning, & Begovich, 1994; Lu et al., 1990; Magnusson et al., 2001) and longevity (Ivanova et al., 1998) . Of particular interest is the mapping of breast cancer (de Jong et al., 2003) and Hodgkin lymphoma susceptibility (Diepstra et al., 2005) to the MHC class III region, which is devoid of classical HLA genes. During the GWAS era, disease associations with MHC region variants have drastically increased (Lenz, Spirin, Jordan, & Sunyaev, 2016; Ripke et al., 2013; Vandiedonck & Knight, 2009) (Figure 1 ). GWAS have identified SNP level associations for most robustly validated HLA associations (Table 3 ). Autoimmune disorders have always shown strong and consistent MHC associations (Matzaraki, Kumar, Wijmenga, & Zhernakova, 2017 ) some of which have been even narrowed down to amino acid level (Achkar et al., 2012; Miyadera, Ohashi, Lernmark, Kitamura, & Tokunaga, 2015; Raychaudhuri et al., 2012) , but detailed studies also show independent associations with non-HLA polymorphisms in the MHC region (Handunnetthi, Ramagopalan, Ebers, & Knight, 2010; Rioux et al., 2009 ).
Progress has been made in understanding the mechanisms of several HLA-associated diseases (Caillat-Zucman, 2009; Sollid, Pos, & Wucherpfennig, 2014) , especially in rheumatoid arthritis (Klareskog, Catrina, & Paget, 2009) , type 1 diabetes and coeliac disease (Busch et al., 2012) , as well as drug hypersensitivities (Illing, Vivian, Purcell, Rossjohn, & McCluskey, 2013) . However, given the number of disease associations with MHC region variants, only a small number of potential mechanisms have been uncovered (Howell, 2014) .
| UNIQUE FEATURES OF THE EXTENDED MHC REGION
The HLA region has many unique features which distinguish it from the rest of the genome (Box 1). The two most gene-dense regions of the human genome are the MHC class III region and the histone gene supercluster within the xMHC region (Xie et al., 2003) . Besides being the most gene dense, xMHC is also the most polymorphic region in the genome, which is compounded by a complex linkage disequilibrium (LD) structure. In the xMHC, individual SNPs and haplotypes are as relevant as elsewhere, additionally, constellations of them make up HLA alleles, groups of HLA alleles form functional T A B L E 1 Descriptive information on genome coordinates, gene content and polymorphisms of the classical MHC region (Dilthey et al., 2013; A. T. Dilthey, Moutsianas, Leslie, & McVean, 2011; Jia et al., 2013; M. Xie, Li, & Jiang, 2010; X. C. Zhang, Li, Wang, Hansen, & Zhao, 2011), but no GWAS to date has specifically examined the MHC region for functional polymorphisms such as highly functional epitopes (including HLA-Bw4/Bw6 or HLA-C1/C2) that have previously shown important disease associations (discussed later).
An important difference in the xMHC from the rest of the genome concerns the structural variation and the presence of closely related genes in these regions. Two such regions contain the complement (C2, C4A, C4B in a CNV region) and HLA-DRB (B1-B9) genes (a segmental duplication region). The polymorphisms in these regions are particularly difficult to genotype using high-throughput methods, mainly because they violate Hardy-Weinberg equilibrium (HWE) due to the presence of paralogs and CNV. An analysis of the whole genome sequencing data from the 1000 Genomes Project revealed that the MHC region shows the highest Hardy-Weinberg disequilibrium levels (Graffelman, Jain, & Weir, 2017) . Most of this must be due to the genomic features of this region. SNPs that do not conform to HWE are excluded from GWAS chips at the time of quality control steps during the production phase. At the time of the first wave of GWAS, and CYP21A2 genes within the class III region; (ii) HLA-DR subregion:
just four SNPs in the 114.5 kb subregion covering the area flanked by HLA-DRA and -DRB1 genes. Extreme variation of this region, including structural variation and presence of paralogs, creates difficulties for inclusion of many SNPs in GWAS chips, but alternative genotyping methods exist (Dorak, 2007) . Imputation of the SNPs in the subregions that are not covered sufficiently in GWAS chips may be thought of as a solution. The success of imputation, however, depends on the reference panel used, and even 1KG data may not be ideal for these structural variation regions, which also suffers from SNP genotype call difficulties for the MHC (Brandt et al., 2015) . CNVs at appreciable population frequencies and with sizes reaching up to 421,697 bp (Conrad et al., 2010; de Smith et al., 2007 (Blanchong et al., 2000) . The RCCX module copy number, each module's size and gene content, and each C4 gene's size on each HLA haplotype are variable (Blanchong et al., 2000; Collier et al., 1989; Y. L. Wu et al., 2007; Y. L. Wu et al., 2008) .
GWAS is unable to detect any of these variations, and as has been pointed out elsewhere (Traherne, 2008) , there is no known proxy SNP for any of these alterations. The only complementary study that has been carried out to follow up any GWAS specifically for this region is in schizophrenia and identified copy number variation of C4 genes as the causal variation (Sekar et al., 2016) .
The frequency of a partial C4A or C4B protein deficiency in the Caucasian populations is between 25.5 and 33.5% (Hauptmann, Tappeiner, & Schifferli, 1988) making partial C4 deficiency the most common immune protein deficiency in humans. C4A deletion is also an established risk marker for systemic lupus erythematosus as well as other autoimmune disorders and infectious diseases (Hauptmann et al., 1988 The HLA and disease associations are based on (Trowsdale & Knight, 2013) with some additions. GWAS data was extracted from GRASP v2.0.0.0 (https:// grasp.nhlbi.nih.gov) and EBI GWAS Catalog (http://www.ebi.ac.uk/gwas). b Chromosome 6 positions are hg19 coordinates. c These GWAS associations correspond to the known HLA allelic associations. d The psoriasis association is the statistically most significant association in any GWAS.
physical deletion of the gene. Nevertheless, no form of C4A deletion is represented by any polymorphisms on current GWAS chips.
The complement proteins have common and useful polymorphisms that were used to define complotypes as constellations of complement components C2, factor B, C4A and C4B. The complotypes were considered as the most informative molecular markers defining the common HLA haplotypes in the 1980s and 1990s (Simon et al., 1997; Whitehead et al., 1984) . Polymorphisms of these genes were used to determine HLA haplotype identity in HLA-matched transplant pairs [Dorak, 1993 . However, once PCR-based genotypings took over, interest in complotypes faded. or -DRB4 in its place. Another implication is that the -DRB3 or -DRB4
genes are themselves polymorphic genes (Robbins et al., 1997) , but their variants are not included in GWAS chips as they do not map to the reference sequence.
The structural variation in this region is not currently considered in the analysis of data. Two problems arise that may result in the loss of otherwise useful information. First is the presence of duplication products of the ancestral DRB gene confounds genotyping, and secondly, the presence of a SNP in the paralogous position (i.e. a pseudoSNP) may result in excess heterozygosity and violation of HWE (Leal, 2005) , as has been specifically documented for the xMHC SNPs in the 1KG data (Brandt et al., 2015) . These difficulties for genotyping are in addition to the extreme polymorphism of the region which makes it very difficult to design typing assays.
The number of closely related DRB genes is six (DRB1/4/6/7/8/9) on the HLA-DRB1*0401 haplotype. The overall structural variation creates an anomalous situation in that some SNP positions may not even be present in some haplotypes. The
Box 1 Unique features of the xMHC relevant to GWAS
• Most gene dense in the genome (Xie et al., 2003 ).
• Paralog regions and genes (one-third of the genes residing in the MHC have paralogous copies) (Endo, Imanishi, Gojobori, & Inoko, 1997; Horton et al., 2004; Kasahara, 1999a,b; Kasahara et al., 1996; Katsanis et al., 1996; Shiina et al., 2001 ).
• Clustering of functionally related genes (Horton et al., 2004; Trowsdale & Knight, 2013 ).
• Strongest trans-eQTLs (Fairfax et al., 2012; Fehrmann et al., 2011; Westra et al., 2013) and meQTLs (van Dongen et al., 2016) in the genome as well as an exceptional number of connected components in genotype networks (Dall'Olio et al., 2014 ).
• CNV and structural variation (Andersson, 1998; Blanchong et al., 2000; Zhang, Li, Zhang, Wang, & Yu, 2012 ).
• Extremely polymorphic at the nucleotide level (Durbin et al., 2010; Gaudieri, Dawkins, Habara, Kulski, & Gojobori, 2000; Vandiedonck & Knight, 2009 ).
• Highest trait-associated variant density even by standard analysis of GWAS data (treating the xMHC as anywhere else in the genome) (Lenz et al., 2016; Ripke et al., 2013; Vandiedonck & Knight, 2009 ).
• Non-HLA genes throughout xMHC carry deleterious variants at high frequencies (more than two orders of magnitude above the genomewide average for some of them) (Lenz et al., 2016 ).
• Very high linkage disequilibrium over very long range resulting from conserved extended haplotypes (Ahmad et al., 2003; Aly et al., 2006; Blomhoff et al., 2006; Consortium, The MHC Sequencing, 1999) due to lower recombinational rates than the rest of the genome (3-fold lower than 1.2 cM/Mb) (de Bakker et al., 2006 ).
• Higher than average rates of alternative splicing as a manifestation of DNA sequence diversity (Vandiedonck et al., 2011) • Highest gene expression levels across the genome *; highest heritability of gene expression levels (Wright et al., 2014) ; and trans-generational inheritance of methylation patterns (McRae et al., 2014 SNPs in a region that is larger than 50 kb corresponding to the second expressed DRB gene region.
The xMHC region is also very rich in paralog genes as a result of genomic duplications in the past, which are common events (AbiRached, Gilles, Shiina, Pontarotti, & Inoko, 2002; Flajnik & Kasahara, 2010; Kasahara, 1999a; Katsanis, Fitzgibbon, & Fisher, 1996) . Nearly one-third of the genes residing in the MHC have paralogous copies in at least one of the three regions established to be paralogous to MHC on 9q33-q34, 1q21-q25/1p11-p32 and 19p13.1-p13.3 (Horton et al., 2004; Kasahara, 1999a; Shiina et al., 2001 ). An example of paralogy within the MHC is the CYP21A2 gene, which is adjacent to its pseudogene CYP21A1P. Very high sequence similarity between these two paralogs complicates genotyping efforts. CYP21A2 encodes 21-hydroxylase and is the cause of the most common autosomal recessive condition of childhood, congenital adrenal hyperplasia (CAH; OMIM 201910). 21-hydroxylase is involved in adrenal sex steroid biosynthesis and is likely to play a role in hormonally mediated conditions, which may include breast cancer (Woolcott et al., 2010; X. Zhang, Tworoger, Eliassen, & Hankinson, 2013) . No GWAS on any condition has ever examined any polymorphism of CYP21A2, and any data on polymorphisms of this gene have been generated by conventional methods as is routinely done in medical genetics laboratories. The most common mutation of CYP21A2 that is involved in late-onset CAH is V282L (rs6471), which is listed in dbSNP with some data showing the mutant allele frequency up to 0.540 in some populations obviously due to genotyping error. The problem with CYP21A2 genotyping by high-throughput methods is specifically due to the interference by its pseudogene CYP21A1P that lies adjacent to the active gene.
Another example of paralogy is the heat shock protein (HSP) genes HSPA1A, HSPA1B and HSPA1L. These three genes are extremely similar in their sequences, and part of a large HSP superfamily (Calderwood & Ciocca, 2008) . As a result, their genotyping is extremely difficult 
| xMHC REGION ASSOCIATIONS IN GWAS
Although the earliest serological associations with autoimmune diseases stood the test of time (Brewerton et al., 1973; Stastny, 1978) , due to the presence of many inconclusive and inconsistent reports, pre-GWAS era HLA-disease associations were often met with some scepticism. It is unfortunate that most of those HLA association studies indeed did not conform to the current standards of genetic epidemiological research, and may have suffered from small sample size, methodological imperfections including HLA typing errors, disregard of population structure and lack of replication.
GWAS have unravelled many unsuspected susceptibility markers for many traits (Manolio, 2013 (Profaizer & Eckels, 2012) .
Cancer susceptibility is historically linked to the histocompatibility loci. The earliest disease susceptibility study in animals examining MHC effects highlighted its role in leukaemia in mice (Lilly, Boyse, & Old, 1964) followed by other cancers (Oomen, Van der Valk, & Den Engelse, 1983 ) including breast (Dux & Demant, 1987; Muhlbock & Dux, 1974; Ropcke, Moen, Hart, & Demant, 1990 ) and lung cancer (Demant, Oomen, & Oudshoorn-Snoek, 1989; Oomen et al., 1983; Snoek et al., 2000) . Those studies were not limited to virally induced leukaemia and mammary tumours, but also examined spontaneous, chemically and hormonally induced tumours. Until the GWAS era, replicated associations were few and far in between. In the GWAS era, robust associations have emerged in lung cancer (Broderick et al., 2009; Guo et al., 2011; Y. Wang et al., 2008) , breast cancer (Michailidou et al., 2015) , prostate cancer (Kote-Jarai et al., 2011), testicular germ cell tumour (Rapley et al., 2009 ), liver cancer (Kumar et al., 2011) , multiple myeloma (Chubb et al., 2013) , Hodgkin lymphoma Urayama et al., 2012) , follicular lymphoma (Conde et al., 2010) , nasopharyngeal carcinoma (Tse et al., 2009) , cervical cancer and glioma (Bethke et al., 2008) . As in other diseases, with increasing use of rare variants, much larger sample sizes and metaanalysis approaches in association studies, more associations are being reported (Fitzgerald et al., 2013; Haiman et al., 2013; Kuchenbaecker et al., 2015; Timofeeva et al., 2012; C. Wu et al., 2014) . 
| WHAT GWAS COULD HAVE SHOWN
It is clear that GWAS have unravelled many unexpected associations throughout the genome including the xMHC. GWAS catalogue and other similar databases list thousands of associations from the xMHC, but their independence from one another and from HLA types already known to be associated with the same trait is not always examined. What GWAS has achieved has achieved is generally considered impressive, but more could have been done for the analysis of xMHC polymorphisms. At present, there are more than 16,000 HLA alleles (Table 1) There are already recognized associations with diseases or physiologic traits of some of these dimorphisms and other broad groupings,
Box 2 Potential reasons for disproportionate number of disease associations with xMHC region SNPs
• Extreme polymorphism (Durbin et al., 2010; Gaudieri et al., 2000) .
• Extreme diversity of gene content (Horton et al., 2004; Shiina et al., 2009 ).
• Pleiotropic (immune and nonimmune) functions of HLA molecules (Hassan & Mourad, 2011; Truman, Garban, Choqueux, Charron, & Mooney, 1996) .
• Selection acting on HLA loci and hitchhiking of deleterious alleles with them (Lenz et al., 2016; Mathieson et al., 2015) .
• Presence of strongest trans-eQTLs (Fehrmann et al., 2011; Westra et al., 2013) and meQTLs (van Dongen et al., 2016) in the genome
• Effect of HLA alleles on the microbiome (Kubinak et al., 2015; Marietta, Rishi, & Taneja, 2015) . Dedicated genotyping assays are available for the better known dimorphisms: HLA-Bw4/Bw6 (Bari et al., 2011; Ugolotti et al., 2011; Yun et al., 2007) and HLA-C1/C2 (Bari et al., 2011; Schellekens et al., 2007; Ugolotti et al., 2011; Yun et al., 2007) as well as for HLA-DPB1 (Cano & Fernandez-Vina, 2009 ) dimorphisms, which can be used in secondary studies following GWAS.
Currently, the HLA region is treated the same as any other region in the genome in GWAS data analysis, if not excluded from data analysis (see for example, Ref. (Deelen et al., 2014) ). The HLA region has unique characteristics that need to be considered in data analysis. The most popular multi-allelic HLA grouping currently in use for disease association studies is the DRB1 alleles bearing the "shared epitope" relevant in rheumatoid arthritis aetiology. HLA-DRB1 alleles with amino acid sequences QKRAA, QRRAA or RRRAA at positions 70-74 (shared epitope) are usually analysed as a single cluster in RA association studies (Barnetche, Constantin, Cantagrel, Cambon-Thomsen, & Gourraud, 2008; Bax, van Heemst, Huizinga, & Toes, 2011 
| STATISTICAL ANALYSIS OF THE x HLA REGION GWAS DATA
The xMHC region is currently analysed as anywhere else in the genome in GWAS. From the routine use of the additive model to the traditional thresholds for statistical significance, this approach is potentially counter-productive for detecting associations in this region.
Besides, the unique features of xMHC previously discussed need to be taken into account for most effective analysis of the data from this region.
| Confounding by genomic features of the xHLA region
When the unique features of the HLA region are not taken into account in GWAS analysis, a lot of data may be wasted. Dismissal of SNPs due to violation of HWE resulting from the presence of paralogs or CNV, and low genotype call rates because of structural variation (absence/presence polymorphisms) are a couple of examples of loss of valuable data. Most of these SNPs are eliminated during the SNP selection process for the GWAS chip, and if they make it to the chip, they face a similar outcome at the analysis phase. An example is the common deletion of the C4A gene. Currently, the number of C4A genes in the diploid genome is not determined prior to the analysis and all samples with zero (rare), one, two or more copies of C4A gene are analysed together. We believe the resulting problems with HWE are the main reasons for lack of data from the complement region of the MHC. SNPs in such regions can be genotyped by alternative methods to assess their contribution to disease risk. Thus, as far as the MHC region is concerned, no GWAS is truly genomewide until highly functional regions of the MHC region are genotyped by complementary approaches.
Besides exclusion of SNPs due to genomic features of the region, the reliance on a single reference sequence based on just one HLA haplotype is also problematic. All HLA haplotypes are different in their length due to variable gene content, and the differences can be very large (Horton et al., 2008) . This issue has recently been addressed and a new method based on a population reference graph for analysis of HLA region data is introduced (Dilthey, Cox, Iqbal, Nelson, & McVean, 2015) . This method takes into account the sequencing data from eight common HLA haplotypes. While expected to be of primary use for mapping sequencing reads, it may also help with interpretation of the genotyping results where the current set of reference sequences is substantially incomplete (Dilthey et al., 2015) .
| Linkage disequilibrium
LD in the genome is important for the success of association studies and in the interpretation of results. High LD regions pose difficulty in identification of causal variants among the statistically similar SNP (ssSNP) set that has generated the association signal. LD varies in different parts of the genome and among populations, sometimes causes associations to disappear in a replication study or even to change their directions because of high correlation. High and long-range LD is interpreted as one of the hallmarks of the MHC (T. M. S. Consortium, 1999 ) with some haplotypes being better known for their long-range LD than others.
LD extends over larger physical distances in xMHC than in the rest of the genome (31.1 kb vs 22.3 kb), but these blocks are shorter in genetic distances (0.012 cm vs 0.017 cm) (Vandiedonck & Knight, 2009 ). While on average the extent of LD may appear to be similar to elsewhere in the genome, a haplotype-specific LD variation has long been known (Ahmad et al., 2003; Cullen, Perfetto, Klitz, Nelson, & Carrington, 2002; Gregersen et al., 1988; Thomsen et al., 1994) .
As has already been known (Worwood et al., 1997) , when assessed by the half-length of LD, the HLA-B*0801 haplotype had an extraordinary degree of LD compared with the HLA-B*1801 haplotype (3.5 vs 0.4 Mbp) (Cullen et al., 1997) . As a result of haplotypic variation in LD, the D' values calculated on different HLA backgrounds show large variations in strength and extent (Blomhoff et al., 2006) . As a consequence of haplotype frequency variation, the extent of global LD, the haplotype blocks constructed and the tags selected might be different in different studies of the xMHC region. Thus, the underlying HLA haplotypic architecture is an important parameter to take into account when constructing LD maps of the xMHC (Blomhoff et al., 2006) .
| Definition of statistical significance
Rather than using a traditional p value threshold, both odds ratios and p values may be taken into account for selection of SNPs. This hybrid approach has been shown to be superior to the ranking of SNPs by their p value in a simulation study (Wang & Shete, 2011) . It has been shown that many of nonsignificant but "suggestive" SNPs may be associated with the disease (Lipman et al., 2011) , but are missed due to the statistical threshold used. Replication of findings not exceeding the strict threshold in the first study should be considered as an equally valid approach in exploratory studies (Chanock et al., 2007) .
The associations of susceptibility alleles will rarely reach the required level of significance in GWAS if a Bonferroni correction is used, and the number of false negatives is likely to be large (Rice, Schork, & Rao, 2008) . The drawbacks of Bonferroni type manipulations have been recognized, and solutions have been described (Lipman et al., 2011; Shi et al., 2011) . The main approach for handling the multiple comparisons issue is becoming the false discovery rate (FDR) procedure, which provides adequate protection against type I error (Benjamini & Hochberg, 1995; Sabatti, Service, & Freimer, 2003) . The FDR procedure is easy to apply and not as conservative as the Bonferroni correction. Thus, it does not increase the type II error rate while reducing type I error rate. The biological significance has received much less emphasis than statistical significance in GWAS. There are examples in the literature that statistical significance does not necessarily correlate with biological significance. For example, in GWAS for type 2 diabetes, PPARG rs1801282, one of the best replicated genetic effects with known functional correlation for this phenotype, has p values of .83, .019, .0013 in the individual studies and a value of 1.7 × 10 −6 in the combined analysis of over 32,000 subjects (Williams et al., 2007) .
It is unlikely that this gene would be highlighted were it not for prior knowledge (Williams et al., 2007) .
| Model choice and multi-SNP approaches
GWAS data are generally analysed using the additive genetic model assuming a uniform, linear increase in the odds ratio from wild-type genotype to heterozygous genotype and to variant homozygous genotype. This model is shown to be powerful enough to detect dominant effects, but may be underpowered to detect recessive or overdominant effects (Bush & Moore, 2012; Salanti et al., 2009 ). The extreme polymorphism of the HLA genes is due to balancing selection that encourages heterozygosity, and heterozygote advantage for HLA polymorphisms has been shown in infectious (Carrington et al., 1999) and autoimmune diseases (Nelson et al., 2004) . Thus, currently overdominant model associations, which are common in the MHC region, are undetectable in GWAS data.
It has also been pointed out that exclusively recessive-fit or exclusively dominant-fit associations may be missed as a result of routine use of the additive model (Lettre, Lange, & Hirschhorn, 2007; Salanti et al., 2009; Sellers, 2004; Vukcevic, Hechter, Spencer, & Donnelly, 2011; Zheng et al., 2007) . This issue is particularly problematic for the recessive model, especially when the minor allele frequency is not close to 50% (Freidlin, Zheng, Li, & Gastwirth, 2002; Lettre et al., 2007; Zheng et al., 2007) . Examples of unravelling genetic associations when the best fitting association model is used have been presented in the literature (Puschmann et al., 2011; Salanti et al., 2009) . Specifically, the existence of nonadditive effects in the HLA region has been reported at least in autoimmune disorders (Goudey et al., 2017; Lenz et al., 2015) . To overcome the potential of missing associations in nonadditive models with the exclusive use of the additive model, one can either analyse the data under each model or if the inheritance model is not known, use a robust approach such as maximin efficiency robust test (MERT) or the maximum test (MAX) (Conneely & Boehnke, 2007; Freidlin et al., 2002; Gonzalez et al., 2008; Li, Yu, Li, & Zheng, 2008) .
The testing of multiple genetic models for genomewide genotype data can now be achieved online using GWAR even by inexperienced users (Dimou, Tsirigos, Elofsson, & Bagos, 2017) .
The least absolute shrinkage and selection operator (LASSO), a shrinkage and variable selection method for linear regression penalizing the absolute size of coefficients, has been used for association analysis with a large number of SNPs simultaneously (Ayers & Cordell, 2010; Hoggart, Whittaker, De Iorio, & Balding, 2008; Shi et al., 2011) . MOSGWA is a more recently developed alternative model selection approach, which is based on a modification of the Bayesian Information Criterion (Dolejsi, Bodenstorfer, & Frommlet, 2014) .
MOSGWA detects a number of interesting SNPs for complex diseases, including those in the MHC region, which are not found by other methods. LASSO has been shown to reduce false-positive results while retaining statistical power (Shi et al., 2011) as well as to detect interactions in the MHC region otherwise undetectable (Wu, Devlin, Ringquist, Trucco, & Roeder, 2010) . Although LASSO can simultaneously analyse all SNPs, it does not perform well to detect associations masked by the phenomenon called "unfaithfulness" in regions like the MHC characterized by correlations among markers (Yang et al., 2011) .
Correlation cancellation occurs in regions where so many markers are correlated and their individual contribution to the risk is weakened. In a genomewide survey, associations masked by "unfaithfulness" involving SNPs with at least 1 Mb distance were identified, and all of them were located in the MHC (Yang et al., 2011) . Such associations are unlikely to be detected by standard marginal tests or interaction tests, and the marginal effects of correlated SNPs do not express their significant joint effects faithfully due to the correlation cancellation. These hidden associations can be unmasked by the use of the software called "hidden pattern finder" (Yang et al., 2011) . The unfaithfulness phenomenon has not been considered in the analysis of MHC region data in any GWAS and may have resulted in missing existing associations in the MHC region. The recently proposed "multiple enhancer variant" hypothesis for common traits, which suggests that several variants in LD impacting multiple enhancers may collectively affect gene expression (Corradin et al., 2014) , may well apply to the MHC region associations. If this is the case, correlation cancellation may result in missing such associations.
Bayesian approaches have many advantages over frequentist methods such as including prior information, easier and more intuitive interpretation of results and being more powerful in certain conditions (Balding, 2006) . Bayesian approaches may be particularly attractive to model MHC region associations in GWAS as they are capable of combining different genetic risk models (Stephens & Balding, 2009 ) and modelling the relationships in an integrated "systems biology" manner, for example with hierarchical modelling to jointly evaluate numerous risk markers and covariates (Heron, O'Dushlaine, Segurado, Gallagher, & Gill, 2011; Stephens & Balding, 2009 ) as has been done in earlier HLA association studies (Thomas et al., 1992) . The Bayesian GWAS framework uses external biological and functional genomics-based information to inform prior probabilities of SNP associations, and using priors based on independent functional knowledge could improve the statistical inference, but would be challenging because of heterogeneity and potential bias (Stranger, Stahl, & Raj, 2011) .
| Analysis of additional layers of variation in the classical MHC region
Exploration of HLA alleles, haplotypes, supertypes and lineages as susceptibility markers has not been given much importance in GWAS.
It is practically impossible to run association studies for all HLA alleles defined by DNA sequencing at the highest resolution (n > 16,000
as of March 2017), but algorithms have been developed to predict four-digit HLA alleles from HLA tag SNP data (Karnes et al., 2017) , which has been used successfully (Neville et al., 2017) , and also work in admixed populations (Nunes et al., 2016) . This approach is useful, but there are many other levels of functional MHC specificities as discussed before. These polymorphisms can be incorporated in the analysis of GWAS data either by using proxy SNP constellations (when available) or by manipulating the data after HLA imputation.
The HLA alleles themselves show many important disease asso- (Kennedy, Singh, & Dorak, 2012) It is well known that such groupings exist, but even HLA association studies often fail to consider them. Given the popularity of GWAS and the number of top hits from the MHC, a more complete analysis may reveal associations stronger than existing ones.
In future GWAS analysis, combining conventional sequence variant analysis with the information on tissue-specific eQTL status, CNV, alternative splicing and epigenetic status is expected to be standard procedure and should help most with the analysis of xMHC data.
Besides, the use of population reference graphs to make use of all of the genomic data from this region (Dilthey et al., 2015) , typing for all functional specificities not just for SNPs and HLA types, and the development of novel statistical methods taking into account the LD structure and other genomic features of the region should provide a more complete picture of the involvement of the extended MHC region in disease development.
| CONCLUSION
Here, we contrasted the features of the xMHC region with the rest of the genome, and discussed how these differences may have affected the results from this region in existing GWAS, and how they may result in modifications of design, conduct, analysis and interpretation of future GWAS. The analysis of existing data using standard methods does not have the power to unmask all potential associations. The missing heritability concept for GWAS (Manolio et al., 2009 ) probably applies to the xMHC region more than other regions. This is due to insufficient coverage of the xMHC region in GWAS chips as a natural consequence of enrichment of this region by paralogous genes, extensive CNVs and structural variation. While we cannot thoroughly assess all existing SNPs in the xMHC region, overlooking other layers of functional specificities further contributes to the potential failure of GWAS to detect genetic predisposition conferred by the xMHC region variants. We conclude that despite already showing the highest number of disease associations, the true extent of the involvement of the xMHC region in disease genetics yet to be uncovered.
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